{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:24:45Z","timestamp":1794439485047,"version":"4.9.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","award":["2014"],"award-info":[{"award-number":["2014"]}],"id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background\/aims<\/jats:title><jats:p>Primary sclerosing cholangitis (PSC) is a chronic inflammatory biliary disease for which the immunopathological basis remains an enigma. Natural killer (NK) cells are key components of innate immunity and seemingly play diversified roles in different autoimmune disorders (AIDs). The aim of this study was to determine the role of NK cells in the pathogenesis of PSC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The frequency and phenotype of circulating NK cells in a large cohort of patients with PSC and healthy controls (HCs) were systematically examined. In addition, the functional capacity of NK cells including cytotoxicity and cytokine production was studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The frequency of CD3<jats:sup>\u2212<\/jats:sup>CD56<jats:sup>dim<\/jats:sup>CD16<jats:sup>+<\/jats:sup> (defined as CD56<jats:sup>dim<\/jats:sup>) NK cells in PSC patients was significantly lower in comparison to HCs. CD56<jats:sup>dim<\/jats:sup> NK cells from PSC displayed a more immature phenotype including high expression of the natural killing receptor NKp46 and downregulation of the highly differentiated NK cell marker CD57. Interestingly, the reduction of CD57 expression of NK cells was associated with the disease severity of PSC. In addition, PSC CD56<jats:sup>dim<\/jats:sup> NK cells exhibited increased CD107a degranulation and cytolytic activity toward target cells compared with HCs. Further analysis demonstrated that CD57<jats:sup>\u2212<\/jats:sup>CD56<jats:sup>dim<\/jats:sup> NK cells from PSC had elevated expression of NKp46, NKp30, IL-2 receptor, and KLRG1 and higher cytotoxic capacity as compared to CD57<jats:sup>+<\/jats:sup>CD56<jats:sup>dim<\/jats:sup> NK cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data demonstrate that the differentiation of PSC NK cells is dysregulated with enhanced cytotoxic activity. This change is likely to be functionally involved in pathogenesis and disease progression, deducing the potential of NK-directed immunotherapy for PSC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.912961","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T08:17:31Z","timestamp":1660724251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis"],"prefix":"10.3389","volume":"13","author":[{"given":"Bin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Xiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weici","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S. C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Song","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1730950","article-title":"Recurrent primary sclerosing cholangitis: Current understanding, management, and future directions","volume":"41","author":"Leung","year":"2021","journal-title":"Semin Liver Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nri3566","article-title":"Natural killer cells: a virtual pick and mix","volume":"13","author":"Leavy","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622306","article-title":"The role of natural killer cells in autoimmune diseases","volume":"12","author":"Kucuksezer","year":"2021","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jhep.2007.01.032","article-title":"Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis","volume":"46","author":"Karlsen","year":"2007","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.24041","article-title":"Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism","volume":"120","author":"Norris","year":"2001","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27543","article-title":"Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles","volume":"34","author":"Wiencke","year":"2001","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.1.131","article-title":"Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis","volume":"49","author":"Bo","year":"2001","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hed.2880170416","article-title":"Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"42","author":"Silvain","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.6RI0917-390R","article-title":"Diversification of human NK cells: Lessons from deep profiling","volume":"103","author":"Wilk","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2019-101343","article-title":"Guideline review: British society of Gastroenterology\/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"12","author":"Nicoletti","year":"2021","journal-title":"Frontline Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1001-5256.2022.01.009","article-title":"[Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)]","volume":"60","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.86","article-title":"The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis","volume":"14","author":"Tomiyama","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/cei.12046","article-title":"Human intrahepatic biliary epithelial cells engulf blebs from their apoptotic peers","volume":"172","author":"Rong","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201970107","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)","volume":"49","author":"Cossarizza","year":"2019","journal-title":"Eur J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1053\/j.gastro.2010.05.040","article-title":"Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with crohn's disease","volume":"139","author":"Takayama","year":"2010","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bjorkstrom","year":"2010","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: Development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00422","article-title":"Functional significance of CD57 expression on human NK cells and relevance to disease","volume":"4","author":"Nielsen","year":"2013","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/S0140-6736(15)60360-9","article-title":"Natural killer cell maturation markers in the human liver and expansion of an NKG2C+KIR+ population","author":"Hydes","year":"2015","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.647358","article-title":"Natural killer cell integrins and their functions in tissue residency","volume":"12","author":"Shannon","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaut.2015.08.011","article-title":"Human liver-resident CD56(bright)\/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways","volume":"66","author":"Hudspeth","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00909","article-title":"The natural cytotoxicity receptors in health and disease","volume":"10","author":"Barrow","year":"2019","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ni1322","article-title":"Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1","volume":"7","author":"Gazit","year":"2006","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102461","article-title":"Recognition and prevention of tumor metastasis by the NK receptor NKp46\/NCR1","volume":"188","author":"Glasner","year":"2012","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304472","article-title":"The paradox of NKp46+ natural killer cells: drivers of severe hepatitis c virus-induced pathology but in-vivo resistance to interferon alpha treatment","volume":"63","author":"Pembroke","year":"2014","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.604894","article-title":"Novel immune subsets and related cytokines: Emerging players in the progression of liver fibrosis","volume":"8","author":"Wan","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.05.013","article-title":"Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes","volume":"37","author":"Schulthess","year":"2012","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6401969","DOI":"10.1155\/2020\/6401969","article-title":"Phenotypic and functional changes in peripheral blood natural killer cells in crohn disease patients","volume":"2020","author":"Samarani","year":"2020","journal-title":"Mediators Inflammation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e105375","DOI":"10.1371\/journal.pone.0105375","article-title":"In situ characterization of intrahepatic non-parenchymal cells in PSC reveals phenotypic patterns associated with disease severity","volume":"9","author":"Berglin","year":"2014","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-282301","article-title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset","volume":"116","author":"Lopez-Verges","year":"2010","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.912961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T10:50:38Z","timestamp":1660819838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.912961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2022.912961"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.912961","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2022.912961.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2022.912961.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2022.912961.s003","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"article-number":"912961"}}